BioCorRx to Participate in the First Annual Orange County Recovery Collaborative Resource Fair
April 13, 2018 07:19 ET
|
BioCorRx Inc
ANAHEIM, CA, April 13, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company), a developer and provider of advanced solutions in the treatment of alcohol and opioid addition, today...
BioCorRx CEO Brady Granier and Legendary Soul Man Sam Moore Appear on Fox Business Network to Discuss the Company's Naltrexone Implant, Which Helps Combat Opioid Addiction
April 09, 2018 12:25 ET
|
BioCorRx Inc
ANAHEIM, CA, April 09, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today...
BioCorRx Provides Business Update for the Full Year Ended 2017
April 06, 2018 07:30 ET
|
BioCorRx Inc
ANAHEIM, CA, April 06, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today...
BioCorRx Comments on President Donald J. Trump’s Initiative to Stop Opioid Abuse
March 20, 2018 10:40 ET
|
BioCorRx Inc
ANAHEIM, CA, March 20, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions,...
BioCorRx Provides Update on New Weight Management Program
March 15, 2018 08:08 ET
|
BioCorRx Inc
ANAHEIM, CA, March 15, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today...
BioCorRx Schedules Business Update Conference Call
March 01, 2018 07:30 ET
|
BioCorRx Inc
ANAHEIM, CA, March 01, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today...
Dr. Joseph DeSanto and BioCorRx Recovery Program Participant Appear on the TV Show, The Doctors
February 15, 2018 08:00 ET
|
BioCorRx Inc
ANAHEIM, CA, Feb. 15, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today...
BioCorRx Announces Results of Pre-IND meeting with FDA for Sustained Release Naltrexone Implant, BICX102
February 12, 2018 09:23 ET
|
BioCorRx Inc
505(b)(2) application plan acceptable per FDA Application will seek dual indications for opioid and alcohol use disorders ANAHEIM, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- BioCorRx...
BioCorRx, Inc. Announces Agreement with Wellness Center in Atlanta Area; Recent Company Interviews
October 08, 2015 08:00 ET
|
BioCorRx
Los Angeles, Oct. 08, 2015 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (OTCQB:BICX), developer of the BioCorRx® Recovery Program, a Medication-Assisted Treatment (MAT) program, announces a new distribution...
BioCorRx, Inc. Announces New Program and Outlines Growth Strategy in Special Letter to Shareholders
September 17, 2015 08:00 ET
|
BioCorRx
Los Angeles, Sept. 17, 2015 (GLOBE NEWSWIRE) -- Dear Fellow Shareholder,
I am writing today to reintroduce you to BioCorRx, Inc. (OTCQB: BICX) and bring you up to date on our recent progress and our...